Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism AACT inhibitors(serpin family A member 3 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC16H17F3N4O2 |
InChIKeyOOUGXIZAHWLQEM-UHFFFAOYSA-N |
CAS Registry1381459-14-8 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Prion Diseases | Preclinical | DE | 30 Jun 2022 |